Copyright
©The Author(s) 2021.
World J Gastroenterol. May 7, 2021; 27(17): 1993-2014
Published online May 7, 2021. doi: 10.3748/wjg.v27.i17.1993
Published online May 7, 2021. doi: 10.3748/wjg.v27.i17.1993
Figure 3 TP73-AS1 physically interacts with miR-128-3p-3p.
A: miR-128-3p and its predicted binding sites in the TP73-AS1 sequence; B: Luciferase activity of pancreatic cancer (PC) cells co-transfected with miRNA mimics and luciferase reporter vectors containing TP73-AS1-WT or TP73-AS1-MUT; C: RNA immunoprecipitation assay of the enrichment of TP73-AS1 in AsPc-1 and Capan-1 transfected with miR-NC or miR-128-3p. Immunoglobulin G was used as negative control; D: Expression levels of miR-128-3p in AsPc-1 and Capan-1 cells transfected with si-control or small interfering RNAs targeting TP73-AS1; E: Expression levels of miR-128-3p in PC tissues and adjacent non-tumor tissues; F: The expression of TP73-AS1 and miR-128-3p exhibits a negative correlation in PC tissues. bP < 0.01. IgG: Immunoglobulin G.
- Citation: Wang B, Sun X, Huang KJ, Zhou LS, Qiu ZJ. Long non-coding RNA TP73-AS1 promotes pancreatic cancer growth and metastasis through miRNA-128-3p/GOLM1 axis. World J Gastroenterol 2021; 27(17): 1993-2014
- URL: https://www.wjgnet.com/1007-9327/full/v27/i17/1993.htm
- DOI: https://dx.doi.org/10.3748/wjg.v27.i17.1993